Enforcement Response Register

AFT Pharmaceuticals Limited

Return to Summary

Parties AFT Pharmaceuticals Limited
Sections Fair Trading Act 10, 13(e)
Description AFT Pharmaceuticals Limited has been warned for likely breaching section 10 and 13(e) of the Fair Trading Act for representations made in their advertisements and on its packaging of the Maxiclear range that gave the impression that each of the four products were specifically formulated to treat particular symptoms when this was not the case.
Resolution Warning letter
Year 2017
Media release Commission issues warnings to GSK and AFT over Voltaren, Panadol and Maxiclear
Downloads